Diagnosis, Nonsurgical Management, and Prevention of LVAD Thrombosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of cardiac surgery

• Publication date

  2014-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jocs.12238PMID 24267706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.

  2014cited by this paper
• Mechanistic Pathway(s) of Acquired Von Willebrand Syndrome with a Continuous-Flow Ventricular Assist Device: In Vitro Findings

  2013cited by this paper
• Imaging of Left Ventricular Device Complications

  2013cited by this paper
• Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy.

  2013cited by this paper
• Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality.

  2013cited by this paper
• From clinical observation to mechanism--Heyde's syndrome.

  2013cited by this paper
• Asymmetric speed modulation of a rotary blood pump affects ventricular unloading.

  2013cited by this paper
• Device exchange after primary left ventricular assist device implantation: indications and outcomes.

  2013cited by this paper
• Failed repeated thrombolysis requiring left ventricular assist device pump exchange

  2013cited by this paper
• Utilization of cardiac computed tomography angiography for the diagnosis of left ventricular assist device thrombosis.

  2012cited by this paper
• From clinical observation to mechanism--Heyde's syndrome.

  2012cited by this paper
• What is the optimal anticoagulation in patients with a left ventricular assist device?

  2012cited by this paper
• Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy

  2012cited by this paper
• 235 Thrombus within the HeartMate II Left Ventricular Assist Device (LVAD): Are All Clots Created Equal?

  2012influential reference
• Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis.

  2012cited by this paper
• Hemolysis from Aortic Regurgitation Mimicking Pump Thrombosis in a Patient with a HeartMate II Left Ventricular Assist Device: A Case Report

  2012cited by this paper
• Advances in Mechanical Circulatory Support Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices

  2012cited by this paper
• Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation

  2012cited by this paper
• Left ventricular assist device thrombosis due to clopidogrel resistance

  2012cited by this paper
• Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device.

  2012cited by this paper
• Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics.

  2012cited by this paper
• The Fourth INTERMACS Annual Report: 4,000 implants and counting.

  2012cited by this paper
• Pulsatile control of rotary blood pumps: Does the modulation waveform matter?

  2012cited by this paper
• Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.

  2012cited by this paper
• The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies.

  2011cited by this paper
• Echocardiography Can Be More Sensitive than Thoracic Computed Tomography in Detecting a Thrombus in the Inflow Cannula of a Continuous Left Ventricular Assist Device

  2011cited by this paper
• Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics.

  2011cited by this paper
• A method for anticoagulation of children on mechanical circulatory support.

  2011cited by this paper
• HeartMate II ventricular assist device thrombosis-an echocardiographic approach to diagnosis: can Doppler evaluation of flow be useful?

  2011influential reference
• Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients.

  2011cited by this paper
• Use of Gated Cardiac Computed Tomography Angiography in the Assessment of Left Ventricular Assist Device Dysfunction

  2011cited by this paper
• Images in Cardiovascular Medicine Ventricular Assist Device-Associated Thrombus

  2011cited by this paper
• Novel application of angiojet rheolytic thrombectomy for massive thrombosis of the native aortic valve and jarvick 2000 ventricular assist device in a patient with end‐stage heart failure

  2011cited by this paper
• Novel J stents reduce the risk of embolic stroke in vitro

  2010cited by this paper
• A novel subcutaneous counterpulsation device: acute hemodynamic efficacy during pharmacologically induced hypertension, hypotension, and heart failure.

  2010cited by this paper
• Novel use of plasmapheresis in a patient with heparin-induced thrombocytopenia requiring urgent insertion of a left ventricular assist device under cardiopulmonary bypass.

  2010cited by this paper
• Recombinant peptides in thrombolysis.

  2010cited by this paper
• Hemodynamic Responses to Continuous versus Pulsatile Mechanical Unloading of the Failing Left Ventricle

  2010cited by this paper
• Heparin-induced thrombocytopenia and cardiac surgery

  2010cited by this paper
• Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.

  2010influential reference
• Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.

  2010cited by this paper
• Catheter-directed thrombectomy and thrombolysis for symptomatic lower-extremity deep vein thrombosis: review of current interventional treatment strategies.

  2010cited by this paper
• The role of echocardiography and other imaging modalities in patients with left ventricular assist devices.

  2010cited by this paper
• Partial mechanical long-term support with the CircuLite Synergy pump as bridge-to-transplant in congestive heart failure.

  2010cited by this paper
• Speed Modulation of the Continuous-Flow Total Artificial Heart to Simulate a Physiologic Arterial Pressure Waveform

  2010cited by this paper
• Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management.

  2010influential reference
• Successful percutaneous management of acute left ventricular assist device stoppage.

  2010cited by this paper
• Images in cardiovascular medicine. Repeated successful thrombolysis of a Jarvik 2000 left ventricular assist device in a patient with noncompaction cardiomyopathy.

  2010cited by this paper
• HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.

  2009cited by this paper
• Platelet dysfunction in outpatients with left ventricular assist devices.

  2009cited by this paper
• Activation of endothelial and coagulation systems in left ventricular assist device recipients.

  2009cited by this paper
• Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?

  2009cited by this paper
• Increased Leukocyte-Platelet Interactions During Circulatory Support With Left Ventricular Assist Devices

  2009cited by this paper
• Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

  2009cited by this paper
• Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.

  2009cited by this paper
• Intraoperative evaluation of the HeartMate II flow estimator.

  2009cited by this paper
• Advanced heart failure treated with continuous-flow left ventricular assist device.

  2009cited by this paper
• Dynamic computed tomography to determine cardiac output in patients with left ventricular assist devices.

  2009cited by this paper
• Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.

  2008cited by this paper
• Successful treatment of ventricular assist device associated ventricular thrombus with systemic tenecteplase.

  2008cited by this paper
• Thrombus formation in a HeartMate II left ventricular assist device.

  2008cited by this paper
• Heparin induced thrombocytopenia in patients with ventricular assistance device bridge-to-transplantation. A case series.

  2008cited by this paper
• Numerical study of blood flow at the end-to-side anastomosis of a left ventricular assist device for adult patients.

  2008cited by this paper
• Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.

  2008cited by this paper
• Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.

  2008cited by this paper
• Design Features, Developmental Status, and Experimental Results With the Heartmate III Centrifugal Left Ventricular Assist System With a Magnetically Levitated Rotor

  2007cited by this paper
• Cerebrovascular accidents in patients with a ventricular assist device.

  2007cited by this paper
• Recurrent device thrombi during mechanical circulatory support with an axial-flow pump is a treatable condition and does not preclude successful long-term support.

  2007cited by this paper
• Perioperative Echocardiographic Examination for Ventricular Assist Device Implantation

  2007cited by this paper
• Echocardiography and cardiac assist devices.

  2007cited by this paper
• Successful fibrinolysis after acute left ventricular assist device thrombosis.

  2007cited by this paper
• Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.

  2007cited by this paper
• IgG classification of anti‐PF4/heparin antibodies to identify patients with heparin‐induced thrombocytopenia during mechanical circulatory support

  2007cited by this paper
• In vivo assessment of a rotary left ventricular assist device-induced artificial pulse in the proximal and distal aorta.

  2006cited by this paper
• Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support.

  2006cited by this paper
• An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent.

  2006cited by this paper
• Left ventricular support by axial flow pump: the echocardiographic approach to device malfunction.

  2005cited by this paper
• Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device.

  2005cited by this paper
• Left ventricular assist device malfunction: an approach to diagnosis by echocardiography.

  2005cited by this paper
• High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device.

  2005cited by this paper
• Vascular thrombosis during support with continuous flow ventricular assist devices: correlation with computerized flow simulations.

  2005cited by this paper
• Long-term follow-up of intramyocardial dissecting hematomas complicating acute myocardial infarction.

  2005cited by this paper
• Pathology in patients with ventricular assist devices: a study of 21 autopsies, 24 ventricular apical core biopsies and 24 explanted hearts.

  2005cited by this paper
• Heparin-Induced Thrombocytopenia Complicating Support by the Berlin Heart

  2005cited by this paper
• The effect of LVAD aortic outflow-graft placement on hemodynamics and flow: Implantation technique and computer flow modeling.

  2005cited by this paper
• Echocardiographic evaluation of the Jarvik 2000 axial-flow LVAD.

  2005cited by this paper
• Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation.

  2005cited by this paper
• Platelet activation markers in patients with heart assist device.

  2005cited by this paper
• Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes.

  2004cited by this paper
• Platelet activation and aggregation profile in prolonged external ventricular support.

  2004cited by this paper
• Extensive Coagulation Monitoring in Patients After Implantation of the MicroMed Debakey Continuous Flow Axial Pump

  2004cited by this paper
• Red vs white thrombi: treating the right clot is crucial.

  2003cited by this paper
• Safety and efficacy of tenecteplase in acute myocardial infarction

  2003cited by this paper
• Heparin-induced thrombocytopenia and cardiac surgery.

  2003cited by this paper
• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• Successful intraventricular thrombolysis during ventricular assist device support.

  2002cited by this paper
• Treatment of Thrombus Formation Associated With the MicroMed DeBakey VAD Using Recombinant Tissue Plasminogen Activator

  2002cited by this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cited by this paper
• Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices.

  2001cited by this paper
• Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.

  2001cited by this paper

• Successful invasive treatment of stroke in a patient with a left ventricle assist device – case report

  2025cites this paper
• Left Ventricular Assist Device in Advanced Refractory Heart Failure: A Comprehensive Review of Patient Selection, Surgical Approaches, Complications and Future Perspectives

  2024cites this paper
• An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device.

  2024cites this paper
• Antithrombotic therapy for durable left ventricular assist devices — current strategies and future directions

  2022cites this paper
• Hemostatic Challenges in Pediatric Critical Care Medicine—Hemostatic Balance in VAD

  2021cites this paper
• Thoracic Transplant Anesthesiology: Keeping Up With Advances and Developments of Allied Specialties

  2020cites this paper
• Clinical Implications of LDH Isoenzymes in Hemolysis and Continuous-flow Left Ventricular Assist Device-Induced Thrombosis.

  2020cites this paper
• High-Speed Visualization of Ingested, Ejected, Adherent, and Disintegrated Thrombus in Contemporary Ventricular Assist Devices.

  2020cites this paper
• Classification of the Frequency, Severity, and Propagation of Thrombi in the HeartMate II Left Ventricular Assist Device

  2020cites this paper
• Hemostatic complications associated with ventricular assist devices

  2019cites this paper
• A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility.

  2019cites this paper
• Tranzitorni signali visokog intenziteta u bolesnika s ugrađenim cirkulacijskim crpkama

  2019cites this paper
• LVAD Occlusion Condition Monitoring Using Boost Classification Trees

  2019cites this paper
• Small Left Ventricular Size Is an Independent Risk Factor for Ventricular Assist Device Thrombosis

  2019cites this paper
• Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice

  2019cites this paper
• In vitro study for the evaluation of transluminal aspiration as a novel treatment option for thrombosis in the HeartWare HVAD

  2018cites this paper
• Facilitating Noncardiac Surgery for the Patient with Left Ventricular Assist Device: A Guide for the Anesthesiologist

  2018cites this paper
• Left Ventricular Assist Device Inflow Cannula Angle and Thrombosis Risk

  2018cites this paper
• Arrhythmias after left ventricular assist device implantation: Incidence and management.

  2018cites this paper
• Medical Therapy As Compared To Surgical Device Exchange for Left Ventricular Assist Device Thrombosis: A Systematic Review and Meta-Analysis

  2018cites this paper
• Argatroban administration as therapy for thrombosis in patients with continuous-flow ventricular assist devices.

  2018cites this paper
• Pediatric ventricular assist device thrombosis

  2017cites this paper
• Direct Thrombin Inhibitor for LVAD Thrombosis: A Closer Look

  2017cites this paper
• Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices.

  2017cites this paper
• Emergency HeartWare Ventricular Assist Device (HVAD) exchange due to pump thrombosis using minimally invasive technique

  2017cites this paper
• Medical Management of Pump-Related Thrombosis in Patients with Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis

  2017cites this paper
• Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.

  2017cites this paper
• Thrombolytics in VAD management — A single-center experience

  2016cites this paper
• Monitoring hemostasis parameters in left ventricular assist device recipients – a preliminary report

  2016cites this paper
• Case Report of Multiembolic Cerebrovascular Event Associated with Ramp Study Echocardiogram

  2016cites this paper
• Systemic Thrombolysis Versus Device Exchange for Pump Thrombosis Management: A Single-Center Experience

  2016cites this paper
• Microfluidic Approaches for the Assessment of Blood Cell Trauma: A Focus on Thrombotic Risk in Mechanical Circulatory Support Devices

  2016cites this paper
• Do patients with a continuous-flow left ventricular assist device benefit from induced-pulsatility or are we just spinning our wheels?

  2015cites this paper
• Echocardiographic Measurement of Left Ventricular Flow Field in LVAD Patients

  2015cites this paper
• Bleeding and Thrombotic Events in Patients Undergoing Mechanical Circulatory Support: A Review of Literature

  2015cites this paper
• Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.

  2015cites this paper
• HeartMate II Left Ventricular Assist Device Geometry on Chest Radiograph Does Not Correlate with Risk of Pump Thrombosis

  2015cites this paper
• Von Willebrand factor in patients on mechanical circulatory support – a double-edged sword between bleeding and thrombosis

  2015cites this paper
• LVADs: Trouble shooting left ventricular assist devices in the emergency department

  2015cites this paper
• Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.

  2015cites this paper
• Hematologic Markers Better Predict Left Ventricular Assist Device Thrombosis than Echocardiographic or Pump Parameters

  2014cites this paper